Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02879318 |
|---|---|
| Brief Title: | Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma |
| First Submitted : | August 22, 2016 |
| First Submitted that Met QC Criteria : | August 22, 2016 |
| First Posted : | August 25, 2016 (Estimate) |
| Results First Submitted : | May 5, 2021 |
| Results First Submitted that Met QC Criteria : | May 5, 2021 |
| Results First Posted : | May 28, 2021 |
| Last Update Submitted that Met QC Criteria : | February 9, 2024 |
| Last Update Posted : | March 12, 2024 |